Condition

Remodeling, Ventricular

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 3 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials3

Recruiting0

Common interventions5

Lead sponsors shown3

Clinical trials

3 shown

Comparison of the Effects of Dapagliflozin and Gemigliptin on Ketone Metabolism and Cardiac Remodeling in Type 2 DiabetesNCT05194592 · 2022-01-07

UNKNOWN

Effect of Doxycycline on Cardiac Remodelling in STEMI PatientsNCT03960411 · 2019-05-25

UNKNOWN

HIIT Effects on Long-term Survival in Heart Failure PatientsNCT05487716 · 2009-01-01

COMPLETED

Common interventions

DapagliflozinDRUG1 Doxycycline 100Mg CapsuleDRUG1 GemigliptinDRUG1 High-intensity interval training (HIIT)BEHAVIORAL1 Placebo oral capsuleDRUG1

Mapped drugs appearing in these trials

Shared trial participation only; not evidence of efficacy or approval.

dapagliflozin1

Leading sponsors

Chang Gung Memorial Hospital 1 Felix Chikita Fredy, MD 1 Wonju Severance Christian Hospital 1

Trial status mix

UNKNOWN2

COMPLETED1

Phase mix

PHASE31

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.